- Home
- CINT vs OCUL Comparison
CINT vs OCUL Comparison
Compare CINT & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CINT
- OCUL
- Stock Information
- Founded
- CINT 1995
- OCUL 2006
- Country
- CINT Brazil
- OCUL United States
- Employees
- CINT N/A
- OCUL N/A
- Industry
- CINT EDP Services
- OCUL Biotechnology: Pharmaceutical Preparations
- Sector
- CINT Technology
- OCUL Health Care
- Exchange
- CINT Nasdaq
- OCUL Nasdaq
- Market Cap
- CINT 833.8M
- OCUL 957.3M
- IPO Year
- CINT 2021
- OCUL 2014
- Fundamental
- Price
- CINT $5.54
- OCUL $7.71
- Analyst Decision
- CINT Buy
- OCUL Strong Buy
- Analyst Count
- CINT 7
- OCUL 10
- Target Price
- CINT $7.61
- OCUL $16.22
- AVG Volume (30 Days)
- CINT 115.3K
- OCUL 1.8M
- Earning Date
- CINT 05-21-2025
- OCUL 05-06-2025
- Dividend Yield
- CINT N/A
- OCUL N/A
- EPS Growth
- CINT 14.74
- OCUL N/A
- EPS
- CINT 0.22
- OCUL N/A
- Revenue
- CINT $438,961,000.00
- OCUL $63,723,000.00
- Revenue This Year
- CINT $533.09
- OCUL $13.32
- Revenue Next Year
- CINT $14.54
- OCUL $13.13
- P/E Ratio
- CINT $25.71
- OCUL N/A
- Revenue Growth
- CINT N/A
- OCUL 9.03
- 52 Week Low
- CINT $3.34
- OCUL $4.06
- 52 Week High
- CINT $8.04
- OCUL $11.78
- Technical
- Relative Strength Index (RSI)
- CINT 50.73
- OCUL 54.41
- Support Level
- CINT $4.78
- OCUL $6.94
- Resistance Level
- CINT $5.13
- OCUL $8.23
- Average True Range (ATR)
- CINT 0.31
- OCUL 0.61
- MACD
- CINT 0.10
- OCUL 0.12
- Stochastic Oscillator
- CINT 86.43
- OCUL 78.60
About CINT CI&T Inc
CI&T Inc is engaged in providing strategy, design, and software engineering services to enable digital transformation for companies. The company mainly develops customizable software through the implementation of several software solutions, including Machine Learning, Artificial Intelligence (AI), Analytics, Cloud, and Mobility technologies. The majority of the revenue is generated from the North America and Europe, followed by Asia, Pacific and Japan.
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.